Last week Pharmaceutical Research and Manufacturers of America (PhRMA) released an infographic depicting how new drug development is actually harder than rocket science.
The industrial manufacturing sector saw increased merger activity in the second quarter,...
The planning and execution of clinical trials is a complex and deliberate process that must...
Atsushi Inoue from Mitsubishi Gas Chemical Company answers questions regarding the pharmaceutical marketplace, covering topics such as regulatory requirements, technology, trends, and recommendations.
Chris Oostyen from Iwata answers questions regarding the pharmaceutical marketplace, covering topics such as regulatory requirements, technology, trends, and recommendations.
Nexvet is developing species-specific monoclonal antibody therapies to treat pain—particularly degenerative joint disease—in cats and dogs.
Many of the powders that are used in the production of pharmaceutical oral solid dosage (OSD) formulations are combustible, and since most operations in pharmaceutical facilities can create explosible atmospheres, dust cloud explosion hazards should be expected.
Learn about this year's upcoming Pharma EXPO, which will be taking place in Las Vegas at the Las Vegas Convention Center Sept. 28–30.
Maintaining the safety of workers and avoiding contamination in an aseptic pharmaceutical manufacturing context, particularly in a cleanroom setting, starts with the right gloves.
Mohan Ponnudurai, Industry Solutions Director at Sparta Systems, discusses the realities and preventability of recalls in today's world.
Readers offer their insights on counterfeiting, compliance levels, investments, and the overall impact of the Drug Supply Chain Security Act.
Digitization of processes and data across the value chain, along with the emergence of the Internet of Things (IoT), has transformed the pharma industry.
Fueled by a 90-year legacy of patient-centric approaches, West Pharmaceutical Services has been able to capitalize on the growth of personalized medicine and the advanced delivery devices it requires.
Jeff Reinke, Editorial Director, hits on key points such as Drug Supply Chain Security Act—specifically how it impacts one's approach to quality.
The MAPI Foundation reduced its growth forecasts for both U.S. GDP and manufacturing production in 2015 and 2016. Manufacturing is not expected to return to its pre-recession peak until the third quarter of next year.
Validation, and associated activities around qualification and calibration, must continue on an on-going basis to ensure that production remains within specification, and does not drift out of compliance over time.
The report added that equity firms showed increased flexibility in the structure of acquisitions, which included complete buyouts and minority investments. Private equity exits from the market increased by more than 20 percent last year.